To include your compound in the COVID-19 Resource Center, submit it here.

Thyrogen thyrotropin alpha regulatory update

EMA's CHMP said Sanofi's Genzyme Corp. subsidiary notified the committee that the supply shortage for thyroid cancer treatment Thyrogen thyrotropin alfa will continue to be restricted until 2012. In March, the company informed the

Read the full 349 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE